OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities
Forough Foolad, Fariba Khodagholi, Seyed Massood Nabavi, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0230691-e0230691
Open Access | Times Cited: 12

Showing 12 citing articles:

Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson’s disease
Yanhua Shen, Qin Wu, Jingshan Shi, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110928-110928
Open Access | Times Cited: 95

TDP43 augments astrocyte inflammatory activity through mtDNA-cGAS-STING axis in NMOSD
Zhuhe Liu, Yunmeng Bai, Bingtian Xu, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access

Future applications of fluorescence lifetime imaging ophthalmoscopy in neuro-ophthalmology, neurology, and neurodegenerative conditions
Daniel Markowitz, Elizabeth Affel, György Hajnóczky, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access

Association between myasthenia gravis and cognitive disorders: a PRISMA-compliant meta-analysis
Xiaoling Zhou, Shugang Cao, Jin-Yi Hou, et al.
International Journal of Neuroscience (2022) Vol. 133, Iss. 9, pp. 987-998
Closed Access | Times Cited: 8

Decipher potential biomarkers of diagnosis and disease activity for NMOSD with AQP4 using LC-MS/MS and Simoa
Jinyang Wang, Jianan Wang, Wei Xie, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109761-109761
Closed Access | Times Cited: 4

Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments
Forough Foolad, Zahra Samadi‐Bahrami, Fariba Khodagholi, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3442-3460
Closed Access | Times Cited: 3

Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
Lingyao Kong, Yanlin Lang, Xiaofei Wang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 5

Anti-AQP4–IgG-positive Leigh syndrome: A case report and review of the literature
Jun Chen, Jianjun Wang, Jing Gan, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 1

Mitochondrial-regulated Tregs: potential therapeutic targets for autoimmune diseases of the central nervous system
Aoya Han, Tingting Peng, Yinyin Xie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1

Mitochondria–A target for attenuation of astrocyte pathology
Marlene Thorsen Mørch, Reza Khorooshi, Joanna Marczynska, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577657-577657
Open Access | Times Cited: 3

Decreased SIRT1 mRNA expression in peripheral blood mononuclear cells from patients with neuromyelitis optica spectrum disorders
Lu Zhang, Yumei Xue, Congcong Yuan, et al.
Acta Neurologica Belgica (2023) Vol. 123, Iss. 6, pp. 2287-2294
Closed Access

Page 1

Scroll to top